Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,506,586
+$434,994 QoQ
Shares Held
9,961
+4.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,783
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglas Lane & Associates, LLC holds $414,684,195 across 11 Drug Manufacturers - General names. ABBV ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
663,667 | $168,551,507 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,556,184 | $89,667,322 | |
| 3 | MRK |
Merck & Co., Inc.
|
552,155 | $70,951,917 | |
| 4 | GSK |
GSK plc
|
946,636 | $49,622,659 | |
| 5 | NVS |
Novartis AG
|
140,152 | $21,964,621 | |
| 6 | AMGN |
Amgen Inc
|
13,032 | $4,719,147 | |
| 7 | LLY |
ELI LILLY & Co
|
2,861 | $3,431,569 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
9,961 | $2,506,586 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,506,586 | 9,961 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,071,592 | 9,525 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,198,302 | 9,621 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $2,312,158 | 9,986 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,918,382 | 10,335 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $2,159,313 | 10,306 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,891,438 | 10,644 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $2,097,435 | 10,621 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,903,185 | 11,096 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $2,114,363 | 11,611 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,857,160 | 11,984 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,996,807 | 13,396 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,672,942 | 12,417 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,937,142 | 12,155 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,079,920 | 12,870 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,880,282 | 14,010 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,084,048 | 13,607 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,218,637 | 13,686 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,882,330 | 13,902 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $1,461,962 | 13,553 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,536,522 | 13,641 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $1,275,805 | 11,789 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $1,193,436 | 11,138 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $916,629 | 10,465 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,088,521 | 11,087 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $870,623 | 11,427 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||